Why WELL Health (TSX:WELL) Stock Is Surging 17% This Week

WELL Health Technologies (TSX:WELL) stock is quickly regaining lost ground as its acquisition spree continues.

| More on:
Overhead shot of young adults using technology at a table

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Telehealth star WELL Health Technologies (TSX:WELL) stock is quickly regaining lost ground. Over the past six days, the stock has surged 17%. It’s now within striking distance of its all-time high of $9.84. Here’s why this stock is gaining attention again and how far this rally could stretch in the year ahead. 

WELL Health stock rebound

WELL Health stock has been tightly correlated with the tech sector and stay-at-home stocks over the past year. Over the course of 2020, the company gained 500% in market value primarily driven by the adoption of the company’s virtual healthcare and medical data services. 

However, with the pandemic receding and growth stocks collapsing, WELL Health stock took a dip too. It’s been down roughly 25% from its all-time high in February. However, there are a number of reasons why WELL Health doesn’t deserve this correlation. 

For one, healthcare technology is insulated from the economy. WELL Health’s traction and adoption are not impacted by economic growth or interest rates. Second, the stock isn’t overvalued like the rest of the tech sector. While high-flying e-commerce and electric vehicle stocks trade at double-digit multiples of annual sales, WELL Health stock is trading at a forward price-to-sales ratio of around four. 

Finally, the company’s growth is driven by acquisitions and expansion in the United States. Yesterday, WELL Health’s CEO Hamid Shahbazi announced that the team has sealed a deal to acquire MyHealth for $206 million. This deal makes WELL Health “…the largest owner-operator of outpatient medical clinics and the leading multi-disciplinary telehealth service provider in Canada,” according to Shahbazi’s tweet. 

News about this acquisition was the perfect catalyst for the stock. It’s up 15% since yesterday. WELL Health seems to have plenty of room to grow further. 

Room to grow

Currently worth about $1.6 billion, WELL Health is still a tiny challenger in a massive market. The healthcare technology sector in North America is worth hundreds of billions. Across the world, this market could be worth trillions. 

The adoption of virtual healthcare and telehealth services was spurred by the pandemic, but it’s here to here to stay now. The convenience of receiving medical attention via video calls is undeniable. Meanwhile, WELL Health is backed by heavyweight investors like Hong Kong billionaire Sir Li Ka-shing. This means it has plenty of dry powder to keep acquiring small firms like MyHealth to sustain this pace of growth. 

Before its latest acquisition, WELL health was on track to generate $300 million in annual recurring revenue. Now, the acquisition probably pushes that number higher. Assuming the stock deserves a price-to-sales ratio of eight to 10, WELL Health stock could easily double in market value by the end of the year. 

Bottom line

WELL Health stock is surging again as news of its latest acquisition is made public. The purchase of MyHealth makes the company the largest private healthcare provider in Canada. This model is also being expanded in the U.S., which means investors have plenty of growth to look forward to. 

If the team can achieve its revenue growth targets and the market can offer a more reasonable valuation ratio, the stock could double before the end of the year. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »